BIOSECURE Nudges Celltrion’s Jump Into CDMO Business

New Drug Development, Other Plans

 
• By Jung Won Shin
  
Celltrion Group Chairman Jungjin Seo
CDMO Subsidiary May Begin To Generate Sales From 2028

More from Strategy

More from Generics Bulletin